232 related articles for article (PubMed ID: 29924019)
1. Case report: successful treatment of refractory SAPHO syndrome with the JAK inhibitor tofacitinib.
Yang Q; Zhao Y; Li C; Luo Y; Hao W; Zhang W
Medicine (Baltimore); 2018 Jun; 97(25):e11149. PubMed ID: 29924019
[TBL] [Abstract][Full Text] [Related]
2. Rapid remission of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome in response to the Janus kinase inhibitor tofacitinib: A case report.
Li B; Li GW; Xue L; Chen YY
World J Clin Cases; 2020 Oct; 8(19):4527-4534. PubMed ID: 33083414
[TBL] [Abstract][Full Text] [Related]
3. Tofacitinib for the Treatment of Nail Lesions and Palmoplantar Pustulosis in Synovitis, Acne, Pustulosis, Hyperostosis, and Osteitis Syndrome.
Li C; Li Z; Cao Y; Li L; Li F; Li Y; Xiong D; Wu X; Zhang W; Zeng X
JAMA Dermatol; 2021 Jan; 157(1):74-78. PubMed ID: 32997094
[TBL] [Abstract][Full Text] [Related]
4. Dramatic response of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome to tofacitinib monotherapy: a case report.
Dierckx S; Nisolle JF; Boutsen Y
J Med Case Rep; 2024 Feb; 18(1):57. PubMed ID: 38360816
[TBL] [Abstract][Full Text] [Related]
5. Tofacitinib, an oral Janus kinase inhibitor, in patients from Brazil with rheumatoid arthritis: Pooled efficacy and safety analyses.
Lomonte ABV; Radominski SC; Marcolino FMD; Brenol CV; Zerbini CAF; García EG; Akylbekova EL; Rojo R; de Leon DP
Medicine (Baltimore); 2018 Aug; 97(31):e11609. PubMed ID: 30075534
[TBL] [Abstract][Full Text] [Related]
6. SAPHO Syndrome Complicated by Ankylosing Spondylitis Successfully Treated With Tofacitinib: A Case Report.
Yuan F; Luo J; Yang Q
Front Immunol; 2022; 13():911922. PubMed ID: 35693775
[TBL] [Abstract][Full Text] [Related]
7. Synovitis, acne, pustulosis, hyperostosis and osteitis syndrome with mandibular involvement: Would surgical operation help?
Liu Y; Wu X; Cao Y; Liu S; Ma M; Li C
Int J Rheum Dis; 2023 Mar; 26(3):563-567. PubMed ID: 36537363
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of a childhood synovitis, acne, pustulosis, hyperostosis and osteitis (SAPHO) syndrome with subcutaneous methotrexate: A case report.
Akçaboy M; Bakkaloğlu-Ezgü SA; Büyükkaragöz B; Isıyel E; Kandur Y; Hasanoğlu E; Buyan N
Turk J Pediatr; 2017; 59(2):184-188. PubMed ID: 29276872
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy outcomes following tofacitinib use for synovitis, acne, pustulosis, hyperostosis and osteitis syndrome: Case report.
Zhang C; Shi X; Ding Y; Lin Z; Qian T; Liu X; Hou X; Li C
Int J Rheum Dis; 2024 Jun; 27(6):e15209. PubMed ID: 38873853
[No Abstract] [Full Text] [Related]
10. [SAPHO syndrome].
Heldmann F; Kiltz U; Baraliakos X; Braun J
Z Rheumatol; 2014 Oct; 73(8):729-41. PubMed ID: 25260820
[TBL] [Abstract][Full Text] [Related]
11. Tofacitinib: A Review in Psoriatic Arthritis.
Paik J; Deeks ED
Drugs; 2019 Apr; 79(6):655-663. PubMed ID: 30895473
[TBL] [Abstract][Full Text] [Related]
12. SAPHO syndrome with Takayasu arteritis successfully treated with tofacitinib.
Ru C; Qian T; Liu X; Wang C; Li W; Hou X; Li C
Int J Rheum Dis; 2023 Jul; 26(7):1381-1383. PubMed ID: 36814398
[TBL] [Abstract][Full Text] [Related]
13. Tofacitinib versus methotrexate in rheumatoid arthritis.
Lee EB; Fleischmann R; Hall S; Wilkinson B; Bradley JD; Gruben D; Koncz T; Krishnaswami S; Wallenstein GV; Zang C; Zwillich SH; van Vollenhoven RF;
N Engl J Med; 2014 Jun; 370(25):2377-86. PubMed ID: 24941177
[TBL] [Abstract][Full Text] [Related]
14. Tofacitinib for the treatment of lichen planopilaris: A case series.
Yang CC; Khanna T; Sallee B; Christiano AM; Bordone LA
Dermatol Ther; 2018 Nov; 31(6):e12656. PubMed ID: 30264512
[TBL] [Abstract][Full Text] [Related]
15. SAPHO syndrome in an adolescent: a clinical case with unusual severe systemic impact.
Freira S; Fonseca H; Ferreira PD; Vasconcelos P; Fonseca JE
J Adolesc Health; 2014 Aug; 55(2):304-6. PubMed ID: 24726464
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
Fleischmann R; Mysler E; Hall S; Kivitz AJ; Moots RJ; Luo Z; DeMasi R; Soma K; Zhang R; Takiya L; Tatulych S; Mojcik C; Krishnaswami S; Menon S; Smolen JS;
Lancet; 2017 Jul; 390(10093):457-468. PubMed ID: 28629665
[TBL] [Abstract][Full Text] [Related]
17. Tofacitinib with conventional synthetic disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis: Patient-reported outcomes from a Phase 3 randomized controlled trial.
Li Z; An Y; Su H; Li X; Xu J; Zheng Y; Li G; Kwok K; Wang L; Wu Q
Int J Rheum Dis; 2018 Feb; 21(2):402-414. PubMed ID: 29314645
[TBL] [Abstract][Full Text] [Related]
18. Exposure-response characterization of tofacitinib efficacy in moderate to severe ulcerative colitis: Results from a dose-ranging phase 2 trial.
Mukherjee A; Hazra A; Smith MK; Martin SW; Mould DR; Su C; Niezychowski W
Br J Clin Pharmacol; 2018 Jun; 84(6):1136-1145. PubMed ID: 29377257
[TBL] [Abstract][Full Text] [Related]
19. Tofacitinib in combination with nonbiologic disease-modifying antirheumatic drugs in patients with active rheumatoid arthritis: a randomized trial.
Kremer J; Li ZG; Hall S; Fleischmann R; Genovese M; Martin-Mola E; Isaacs JD; Gruben D; Wallenstein G; Krishnaswami S; Zwillich SH; Koncz T; Riese R; Bradley J
Ann Intern Med; 2013 Aug; 159(4):253-61. PubMed ID: 24026258
[TBL] [Abstract][Full Text] [Related]
20. Comparing the effects of tofacitinib, methotrexate and the combination, on bone marrow oedema, synovitis and bone erosion in methotrexate-naive, early active rheumatoid arthritis: results of an exploratory randomised MRI study incorporating semiquantitative and quantitative techniques.
Conaghan PG; Østergaard M; Bowes MA; Wu C; Fuerst T; van der Heijde D; Irazoque-Palazuelos F; Soto-Raices O; Hrycaj P; Xie Z; Zhang R; Wyman BT; Bradley JD; Soma K; Wilkinson B
Ann Rheum Dis; 2016 Jun; 75(6):1024-33. PubMed ID: 27002108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
